AAPL 167.04 -0.5714% MSFT 404.33 -1.8235% GOOG 157.46 0.3697% GOOGL 155.9725 0.3232% AMZN 179.17 -1.1639% NVDA 846.71 0.7568% META 501.8 1.544% TSLA 149.9 -3.5703% TSM 132.27 -4.8623% LLY 745.95 -0.642% V 271.36 -0.4877% AVGO 1258.99 -1.8431% JPM 181.25 0.6497% UNH 493.18 2.9625% NVO 122.75 -1.4294% WMT 59.27 -0.637% LVMUY 170.18 -0.3338% XOM 118.47 -0.1349% LVMHF 854.0 -0.4662% MA 454.7 -1.1865%
Last update at 2024-04-18T20:10:00Z
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | -65.70900M | -110.79500M | -17.98700M | -71.97400M | - |
Minority interest | - | - | - | - | - |
Net income | -65.67800M | -107.65900M | -18.11400M | -72.06400M | - |
Selling general administrative | 98.19M | 183.63M | 65.61M | 55.86M | - |
Selling and marketing expenses | 272.59M | 135.90M | 58.99M | 63.16M | - |
Gross profit | 408.72M | 204.49M | 109.45M | 44.60M | - |
Reconciled depreciation | 7.47M | 4.08M | 1.06M | 0.26M | - |
Ebit | -68.69700M | -115.04200M | -15.14400M | -74.41400M | -75.76900M |
Ebitda | -61.22300M | -110.52200M | -16.92000M | -72.29600M | - |
Depreciation and amortization | 7.47M | 4.52M | -1.77600M | 2.12M | - |
Non operating income net other | - | 4.25M | 3.14M | - | - |
Operating income | -68.69700M | -115.04200M | -15.14400M | -74.41400M | - |
Other operating expenses | 595.61M | 386.92M | 163.90M | 156.97M | - |
Interest expense | 2.99M | 3.80M | 0.01000M | 0.37M | 0.00000M |
Tax provision | -0.03100M | -3.13600M | 0.13M | 0.09M | - |
Interest income | - | - | - | - | - |
Net interest income | - | 0.00000M | -0.01000M | -0.36900M | - |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | -0.03100M | -3.13600M | 0.13M | 0.09M | 0.04M |
Total revenue | 526.92M | 271.88M | 148.76M | 82.56M | - |
Total operating expenses | 477.42M | 319.54M | 124.59M | 119.02M | - |
Cost of revenue | 118.19M | 67.38M | 39.31M | 37.95M | - |
Total other income expense net | 2.99M | 4.25M | -2.84300M | 2.44M | - |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -65.67800M | -107.65900M | -3.04901M | -72.06400M | - |
Net income applicable to common shares | -65.67800M | -107.65900M | -18.11400M | -72.06400M | -75.24300M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 366.34M | 420.58M | 118.70M | 72.07M | - |
Intangible assets | 21.84M | 25.89M | 0.06M | - | - |
Earning assets | - | - | - | - | - |
Other current assets | 15.41M | 9.07M | 0.17M | 0.48M | 0.99M |
Total liab | 54.60M | 85.97M | 265.57M | 207.36M | - |
Total stockholder equity | 311.74M | 334.62M | -146.87400M | -135.29300M | - |
Deferred long term liab | - | - | - | - | - |
Other current liab | 12.45M | 55.03M | 1.57M | 11.12M | 0.90M |
Common stock | 0.02M | 0.02M | 0.00500M | 4.50M | - |
Capital stock | 0.02M | 0.02M | 0.00500M | 4.50M | - |
Retained earnings | -344.62900M | -278.95100M | -171.29200M | -153.17800M | -81.11400M |
Other liab | 3.01M | 2.63M | 0.38M | 4.50M | - |
Good will | 110.88M | 110.88M | 0.00000M | - | - |
Other assets | 0.89M | 8.80M | 1.01M | 0.96M | 0.18M |
Cash | 46.77M | 71.78M | 27.34M | 22.65M | - |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 47.94M | 79.22M | 15.23M | 20.62M | 24.11M |
Current deferred revenue | 1.47M | 3.19M | 1.27M | 0.75M | - |
Net debt | -41.46500M | -66.30200M | -27.34400M | -21.13200M | - |
Short term debt | 1.66M | 1.36M | 4.32M | 1.51M | - |
Short long term debt | - | - | - | 1.51M | - |
Short long term debt total | 5.31M | 5.48M | - | 1.51M | - |
Other stockholder equity | 656.63M | 613.69M | 24.42M | 13.38M | -0.00200M |
Property plant equipment | 7.94M | 5.11M | 1.70M | 0.20M | - |
Total current assets | 216.59M | 269.90M | 113.08M | 69.61M | 47.34M |
Long term investments | - | - | 204.53M | 203.11M | - |
Net tangible assets | 170.82M | 197.85M | -149.77400M | -141.09300M | -71.35700M |
Short term investments | 132.85M | 175.49M | 72.86M | 37.72M | - |
Net receivables | 3.23M | 3.58M | 1.15M | 0.86M | 0.50M |
Long term debt | - | - | - | - | - |
Inventory | 21.56M | 13.56M | 3.54M | 4.22M | 3.69M |
Accounts payable | 32.36M | 19.64M | 8.07M | 7.23M | 13.31M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -0.27700M | -0.13700M | -0.01100M | 0.00200M | - |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | 0.02M | 188.54M | 181.24M | - |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | -278.95100M | -1.90175M | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 12.09M | 8.80M | -198.97106M | 2.46M | - |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 149.75M | 150.68M | 5.61M | 2.46M | - |
Capital lease obligations | 5.31M | 5.48M | 0.00000M | - | - |
Long term debt total | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | 34.70M | -104.79300M | -35.46800M | -37.51200M | -37.51200M |
Change to liabilities | 11.01M | 11.27M | 1.34M | -5.86300M | 13.38M |
Total cashflows from investing activities | 34.70M | -156.26800M | -39.70100M | -39.29900M | -0.00800M |
Net borrowings | - | 1.19M | -1.51500M | -6.91500M | 7.43M |
Total cash from financing activities | -33.12700M | 235.04M | 47.74M | 95.32M | 78.15M |
Change to operating activities | -17.19800M | 1.82M | 2.17M | -3.46700M | 0.26M |
Net income | -65.67800M | -107.65900M | -18.11400M | -72.06400M | -75.24300M |
Change in cash | -25.01200M | 44.29M | 5.55M | -18.85300M | 20.82M |
Begin period cash flow | 72.64M | 28.35M | 22.80M | 41.65M | - |
End period cash flow | 47.63M | 72.64M | 28.35M | 22.80M | 41.65M |
Total cash from operating activities | -26.53100M | -34.41200M | -2.47900M | -74.86700M | -57.32200M |
Issuance of capital stock | 0.00000M | 272.69M | 51.90M | 102.57M | - |
Depreciation | 7.47M | 4.08M | 1.06M | 0.26M | 0.26M |
Other cashflows from investing activities | - | -51.47500M | 0.33M | - | - |
Dividends paid | - | - | 1.74M | - | - |
Change to inventory | -8.00400M | -9.62800M | 0.67M | -0.52200M | -2.99700M |
Change to account receivables | - | 1.82M | 1.79M | -3.46700M | - |
Sale purchase of stock | 0.00000M | -22.02700M | 0.00000M | 0.00000M | - |
Other cashflows from financing activities | -35.37300M | -15.61600M | 51.00M | 104.37M | -0.23700M |
Change to netincome | 45.87M | 65.57M | 10.07M | 6.72M | 7.28M |
Capital expenditures | 7.25M | 5.01M | 4.23M | 1.79M | 0.00800M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | 4.54M | -2.06389M | - | - |
Exchange rate changes | - | -0.07300M | - | - | - |
Cash and cash equivalents changes | - | 44.29M | -0.45207M | - | - |
Change in working capital | -14.19500M | 3.46M | 4.19M | -9.85200M | - |
Stock based compensation | 42.82M | 67.21M | 5.83M | 8.03M | - |
Other non cash items | 3.65M | 1.89M | 4.56M | -1.03900M | - |
Free cash flow | -33.77800M | -39.41900M | -6.71200M | -76.65400M | - |
Sector: Consumer Defensive Industry: Household & Personal Products
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
HIMS Hims Hers Health Inc |
-0.07 0.56% | 12.34 | - | 35.59 | 2.34 | 5.58 | 2.28 | -37.1743 |
PG Procter & Gamble Company |
1.34 0.86% | 157.29 | 23.58 | 22.62 | 4.07 | 7.24 | 4.40 | 16.08 |
LRLCF L'Oréal S.A |
11.35 2.55% | 457.05 | 41.14 | 34.25 | 6.52 | 8.59 | 6.67 | 27.76 |
LRLCY L’Oreal Co ADR |
4.96 5.57% | 94.06 | 41.27 | 33.90 | 6.56 | 8.50 | 6.65 | 27.67 |
UL Unilever PLC ADR |
0.16 0.34% | 46.85 | 13.41 | 15.48 | 1.95 | 5.63 | 2.38 | 10.29 |
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
2269 Chestnut Street, San Francisco, CA, United States, 94123
Name | Title | Year Born |
---|---|---|
Mr. Andrew Dudum | Co-Founder, Chairman & CEO | 1989 |
Ms. Melissa Baird | Chief Operations Officer | 1978 |
Ms. Irene A. Becklund | Principal Accounting Officer | 1985 |
Ms. Soleil Teubner Boughton | Chief Legal Officer & Corp. Sec. | 1979 |
Mr. Yemi Okupe | Chief Financial Officer | 1986 |
Mr. Brian O'Shaughnessy | Chief Communications Officer | NA |
Ms. Amee Parekh | Sr. VP of HR | NA |
Mr. Mike Chi | Chief Growth Officer | NA |
Mr. Jonathan Spitzer C.F.A. | Sr. VP of Investor Relations | NA |
Dr. Aimee Paik FAAD, M.D. | Sr. VP & Member of Medical Advisory Board | NA |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).